(LEAD) SK Biopharm's Q3 operating profit up 66 pct on U.S. sales of seizure drug
What the source said
“(LEAD) SK Biopharm's Q3 operating profit up 66 pct on U.S. sales of seizure drug”
SEOUL, Nov. 5 (Yonhap) -- SK Biopharmaceuticals Co., a biopharmaceutical arm of ...
Read at YonhapReported by one source so far. It is confirmed when a second, independent source reports the same thing.